Bill Vincent

Following 25 years in the pharma sector, Bill set out to bring academia and pharma closer together by founding Genezen in 2014. Initially focusing on contract manufacturing, Genezen quickly expanded to include cell manufacturing and testing services. Today, as Executive Chairman, Bill focuses on business strategy, whether that is evaluating new opportunities and technologies, or facilitating activities for Genezen’s clients and employees. Prior to Genezen, Bill was Founder and President at Rimedion (acquired by Ossium Health in 2017).